United States Neuroprotection Market Report 2018

March 2018 | 99 pages | ID: U17F0289AF4EN
QYResearch

Abstracts

In this report, the United States Neuroprotection market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Neuroprotection in these regions, from 2013 to 2025 (forecast).

United States Neuroprotection market competition by top manufacturers/players, with Neuroprotection sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Daiichi Sankyo Company
• Eli Lilly and Company
• Allergan
• Dr. Reddy’s Laboratories
• Teva Pharmaceutical
• Novartis
• AstraZeneca
• Astrocyte Pharmaceuticals
• F. Hoffmann-La Roche
• Biogen

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Free Radical Trapping Agents (Antioxidants)
• Glutamate Antagonists (Anti-Excitotoxic Agents)
• Apoptosis Inhibitors
• Anti-inflammatory Agents
• Neurotrophic Factors (NTFs)
• Metal Ion Chelators
• Stimulants
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Prevention
• Treatment

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Neuroprotection Market Report 2018

1 NEUROPROTECTION OVERVIEW

1.1 Product Overview and Scope of Neuroprotection
1.2 Classification of Neuroprotection by Product Category
  1.2.1 United States Neuroprotection Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Neuroprotection Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Free Radical Trapping Agents (Antioxidants)
  1.2.4 Glutamate Antagonists (Anti-Excitotoxic Agents)
  1.2.5 Apoptosis Inhibitors
  1.2.6 Anti-inflammatory Agents
  1.2.7 Neurotrophic Factors (NTFs)
  1.2.8 Metal Ion Chelators
  1.2.9 Stimulants
  1.2.10 Others
1.3 United States Neuroprotection Market by Application/End Users
  1.3.1 United States Neuroprotection Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Prevention
  1.3.3 Treatment
1.4 United States Neuroprotection Market by Region
  1.4.1 United States Neuroprotection Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Neuroprotection Status and Prospect (2013-2025)
  1.4.3 Southwest Neuroprotection Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Neuroprotection Status and Prospect (2013-2025)
  1.4.5 New England Neuroprotection Status and Prospect (2013-2025)
  1.4.6 The South Neuroprotection Status and Prospect (2013-2025)
  1.4.7 The Midwest Neuroprotection Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Neuroprotection (2013-2025)
  1.5.1 United States Neuroprotection Sales and Growth Rate (2013-2025)
  1.5.2 United States Neuroprotection Revenue and Growth Rate (2013-2025)

2 UNITED STATES NEUROPROTECTION MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Neuroprotection Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Neuroprotection Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Neuroprotection Average Price by Players/Suppliers (2013-2018)
2.4 United States Neuroprotection Market Competitive Situation and Trends
  2.4.1 United States Neuroprotection Market Concentration Rate
  2.4.2 United States Neuroprotection Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Neuroprotection Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES NEUROPROTECTION SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Neuroprotection Sales and Market Share by Region (2013-2018)
3.2 United States Neuroprotection Revenue and Market Share by Region (2013-2018)
3.3 United States Neuroprotection Price by Region (2013-2018)

4 UNITED STATES NEUROPROTECTION SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Neuroprotection Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Neuroprotection Revenue and Market Share by Type (2013-2018)
4.3 United States Neuroprotection Price by Type (2013-2018)
4.4 United States Neuroprotection Sales Growth Rate by Type (2013-2018)

5 UNITED STATES NEUROPROTECTION SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Neuroprotection Sales and Market Share by Application (2013-2018)
5.2 United States Neuroprotection Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES NEUROPROTECTION PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Daiichi Sankyo Company
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Neuroprotection Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Daiichi Sankyo Company Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Eli Lilly and Company
  6.2.2 Neuroprotection Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Eli Lilly and Company Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Allergan
  6.3.2 Neuroprotection Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Allergan Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Dr. Reddy’s Laboratories
  6.4.2 Neuroprotection Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Dr. Reddy’s Laboratories Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Teva Pharmaceutical
  6.5.2 Neuroprotection Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Teva Pharmaceutical Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Novartis
  6.6.2 Neuroprotection Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Novartis Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 AstraZeneca
  6.7.2 Neuroprotection Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 AstraZeneca Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Astrocyte Pharmaceuticals
  6.8.2 Neuroprotection Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Astrocyte Pharmaceuticals Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 F. Hoffmann-La Roche
  6.9.2 Neuroprotection Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 F. Hoffmann-La Roche Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Biogen
  6.10.2 Neuroprotection Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Biogen Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview

7 NEUROPROTECTION MANUFACTURING COST ANALYSIS

7.1 Neuroprotection Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Neuroprotection

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Neuroprotection Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Neuroprotection Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES NEUROPROTECTION MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Neuroprotection Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Neuroprotection Sales Volume Forecast by Type (2018-2025)
11.3 United States Neuroprotection Sales Volume Forecast by Application (2018-2025)
11.4 United States Neuroprotection Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Neuroprotection
Figure United States Neuroprotection Market Size (K Units) by Type (2013-2025)
Figure United States Neuroprotection Sales Volume Market Share by Type (Product Category) in 2017
Figure Free Radical Trapping Agents (Antioxidants) Product Picture
Figure Glutamate Antagonists (Anti-Excitotoxic Agents) Product Picture
Figure Apoptosis Inhibitors Product Picture
Figure Anti-inflammatory Agents Product Picture
Figure Neurotrophic Factors (NTFs) Product Picture
Figure Metal Ion Chelators Product Picture
Figure Stimulants Product Picture
Figure Others Product Picture
Figure United States Neuroprotection Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Neuroprotection by Application in 2017
Figure Prevention Examples
Table Key Downstream Customer in Prevention
Figure Treatment Examples
Table Key Downstream Customer in Treatment
Figure United States Neuroprotection Market Size (Million USD) by Region (2013-2025)
Figure The West Neuroprotection Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Neuroprotection Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Neuroprotection Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Neuroprotection Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Neuroprotection Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Neuroprotection Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Neuroprotection Sales (K Units) and Growth Rate (2013-2025)
Figure United States Neuroprotection Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Neuroprotection Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Neuroprotection Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Neuroprotection Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Neuroprotection Sales Share by Players/Suppliers
Figure 2017 United States Neuroprotection Sales Share by Players/Suppliers
Figure United States Neuroprotection Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Neuroprotection Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Neuroprotection Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Neuroprotection Revenue Share by Players/Suppliers
Figure 2017 United States Neuroprotection Revenue Share by Players/Suppliers
Table United States Market Neuroprotection Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Neuroprotection Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Neuroprotection Market Share of Top 3 Players/Suppliers
Figure United States Neuroprotection Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Neuroprotection Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Neuroprotection Product Category
Table United States Neuroprotection Sales (K Units) by Region (2013-2018)
Table United States Neuroprotection Sales Share by Region (2013-2018)
Figure United States Neuroprotection Sales Share by Region (2013-2018)
Figure United States Neuroprotection Sales Market Share by Region in 2017
Table United States Neuroprotection Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Neuroprotection Revenue Share by Region (2013-2018)
Figure United States Neuroprotection Revenue Market Share by Region (2013-2018)
Figure United States Neuroprotection Revenue Market Share by Region in 2017
Table United States Neuroprotection Price (USD/Unit) by Region (2013-2018)
Table United States Neuroprotection Sales (K Units) by Type (2013-2018)
Table United States Neuroprotection Sales Share by Type (2013-2018)
Figure United States Neuroprotection Sales Share by Type (2013-2018)
Figure United States Neuroprotection Sales Market Share by Type in 2017
Table United States Neuroprotection Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Neuroprotection Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Neuroprotection by Type (2013-2018)
Figure Revenue Market Share of Neuroprotection by Type in 2017
Table United States Neuroprotection Price (USD/Unit) by Types (2013-2018)
Figure United States Neuroprotection Sales Growth Rate by Type (2013-2018)
Table United States Neuroprotection Sales (K Units) by Application (2013-2018)
Table United States Neuroprotection Sales Market Share by Application (2013-2018)
Figure United States Neuroprotection Sales Market Share by Application (2013-2018)
Figure United States Neuroprotection Sales Market Share by Application in 2017
Table United States Neuroprotection Sales Growth Rate by Application (2013-2018)
Figure United States Neuroprotection Sales Growth Rate by Application (2013-2018)
Table Daiichi Sankyo Company Basic Information List
Table Daiichi Sankyo Company Neuroprotection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Daiichi Sankyo Company Neuroprotection Sales Growth Rate (2013-2018)
Figure Daiichi Sankyo Company Neuroprotection Sales Market Share in United States (2013-2018)
Figure Daiichi Sankyo Company Neuroprotection Revenue Market Share in United States (2013-2018)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Neuroprotection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly and Company Neuroprotection Sales Growth Rate (2013-2018)
Figure Eli Lilly and Company Neuroprotection Sales Market Share in United States (2013-2018)
Figure Eli Lilly and Company Neuroprotection Revenue Market Share in United States (2013-2018)
Table Allergan Basic Information List
Table Allergan Neuroprotection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Allergan Neuroprotection Sales Growth Rate (2013-2018)
Figure Allergan Neuroprotection Sales Market Share in United States (2013-2018)
Figure Allergan Neuroprotection Revenue Market Share in United States (2013-2018)
Table Dr. Reddy’s Laboratories Basic Information List
Table Dr. Reddy’s Laboratories Neuroprotection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Dr. Reddy’s Laboratories Neuroprotection Sales Growth Rate (2013-2018)
Figure Dr. Reddy’s Laboratories Neuroprotection Sales Market Share in United States (2013-2018)
Figure Dr. Reddy’s Laboratories Neuroprotection Revenue Market Share in United States (2013-2018)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Neuroprotection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Teva Pharmaceutical Neuroprotection Sales Growth Rate (2013-2018)
Figure Teva Pharmaceutical Neuroprotection Sales Market Share in United States (2013-2018)
Figure Teva Pharmaceutical Neuroprotection Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis Neuroprotection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Neuroprotection Sales Growth Rate (2013-2018)
Figure Novartis Neuroprotection Sales Market Share in United States (2013-2018)
Figure Novartis Neuroprotection Revenue Market Share in United States (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Neuroprotection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Neuroprotection Sales Growth Rate (2013-2018)
Figure AstraZeneca Neuroprotection Sales Market Share in United States (2013-2018)
Figure AstraZeneca Neuroprotection Revenue Market Share in United States (2013-2018)
Table Astrocyte Pharmaceuticals Basic Information List
Table Astrocyte Pharmaceuticals Neuroprotection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Astrocyte Pharmaceuticals Neuroprotection Sales Growth Rate (2013-2018)
Figure Astrocyte Pharmaceuticals Neuroprotection Sales Market Share in United States (2013-2018)
Figure Astrocyte Pharmaceuticals Neuroprotection Revenue Market Share in United States (2013-2018)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Neuroprotection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure F. Hoffmann-La Roche Neuroprotection Sales Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Neuroprotection Sales Market Share in United States (2013-2018)
Figure F. Hoffmann-La Roche Neuroprotection Revenue Market Share in United States (2013-2018)
Table Biogen Basic Information List
Table Biogen Neuroprotection Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Biogen Neuroprotection Sales Growth Rate (2013-2018)
Figure Biogen Neuroprotection Sales Market Share in United States (2013-2018)
Figure Biogen Neuroprotection Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neuroprotection
Figure Manufacturing Process Analysis of Neuroprotection
Figure Neuroprotection Industrial Chain Analysis
Table Raw Materials Sources of Neuroprotection Major Players/Suppliers in 2017
Table Major Buyers of Neuroprotection
Table Distributors/Traders List
Figure United States Neuroprotection Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Neuroprotection Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Neuroprotection Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Neuroprotection Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Neuroprotection Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Neuroprotection Sales Volume (K Units) Forecast by Type in 2025
Table United States Neuroprotection Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Neuroprotection Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Neuroprotection Sales Volume (K Units) Forecast by Application in 2025
Table United States Neuroprotection Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Neuroprotection Sales Volume Share Forecast by Region (2018-2025)
Figure United States Neuroprotection Sales Volume Share Forecast by Region (2018-2025)
Figure United States Neuroprotection Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources